Denali Therapeutics Announces First Patie... - Cure Parkinson's
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Website
Written by
Farooqji
To view profiles and participate in discussions please or .
1 Reply
•
I was accepted to this trial,flew to Long Beach, had 2 days of tests only to discover I was disqualified for having WPW,a heart defect I never knew I had. It stands for Wolf, Parkinson, White. Almost like a cruel joke, having Parkinson’s and a completely unrelated problem with the name Parkinson’s. They still have never reimbursed for my travel expenses.
